Brad Moody, MD
Surgery · Cullman, ALNPI 1073793899
Payments from drug & device makers
What this record shows
This record is dominated by education: $7,013 of the $11,266 with a category attached, or 62.3%. Intuitive Surgical accounts for 68.5% of it on its own, with 46 other manufacturers making up the rest. Reporting peaked in 2019 at $8,748 and has fallen 92.8% since, to $627 in 2025.
Across 180 payments — averaging $62.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$8K
- Organogenesis Inc.$400
- Melinta Therapeutics, LLC$321
- Harmony Biosciences LLC$282
- Integra Lifesciences Corporation$251
- Paratek Pharmaceuticals, Inc.$224
- plus $2K from 41 others
What the payments were for
- Consulting fees$110%
- Travel & lodging$3733%
- Food & beverage$3,86934%
- Education$7,01362%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$7,521
How this compares
$11,266 in reported general payments places this provider in the 85th percentile of 382 surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SutabSod Sulf/Pot Chloride/Mag Sulf | 63 | $10,093 |
| Sucralfate | 38 | $1,400 |
| Omeprazole | 18 | $329 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 47 | $264 |
| Doxycycline Hyclate | 21 | $218 |
| Pantoprazole Sodium | 39 | $210 |
| Ondansetron Hcl | 44 | $195 |
| Famotidine | 13 | $172 |
| Levofloxacin | 31 | $100 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $64 |
| Metronidazole | 12 | $51 |
| Tramadol Hcl | 16 | $18 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Braintree Laboratories, Inc.Sutab | $55 | $10,09363 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 382 surgery providers in Alabama.
Other surgery in Cullman
- D'lisa BitterlyCullman$9K
- John PorterfieldBessemer$972K
- Barton WoodAlabaster$702K
- Forrest RingoldMobile$678K
- Dennis FernandezHuntsville$266K
- Cameron AskewBirmingham$236K
- Terry TreadwellMontgomery$127K
- Charles NewmanGadsden$123K
- Jason BeaverDothan$106K
- John TouliatosBirmingham$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.